No connection

Search Results

Earnings Score 48 Bullish

Galderma Shares Climb as Q1 Sales Surge and 2026 Outlook Confirmed

Apr 23, 2026 08:48 UTC
GDERF, GALD.SW
Short term

Swiss skincare leader Galderma reported a 30.5% jump in first-quarter net sales, driven by robust growth across all business segments. The company reaffirmed its full-year 2026 guidance, sparking a nearly 6% rise in its share price.

  • Net sales increased to $1.47 billion, up 30.5% year-over-year
  • Therapeutic Dermatology sales grew 71.3% (constant currency)
  • Nemluvio revenue jumped from $39 million to $185 million
  • FY26 sales growth guidance maintained at 17% to 20%
  • Core EBITDA margin target confirmed at approximately 26%
  • Shares rose 5.84% to 159.55 francs following the announcement

Galderma Group AG has delivered a strong start to the year, posting first-quarter net sales of $1.47 billion, a significant increase from the $1.13 billion reported in the same period last year. On a constant currency basis, sales grew by 25.5%, reflecting strong volume growth and favorable pricing and mix. The results were bolstered by a broad-based performance across the company's portfolio. The Therapeutic Dermatology segment saw the most explosive growth, with constant currency sales climbing 71.3%, largely fueled by the rapid market adoption of Nemluvio, which generated $185 million in revenue compared to $39 million a year prior. Other segments also outperformed market expectations. Injectable Aesthetics grew 13.1% in constant currency, with neuromodulators and fillers contributing $364 million and $284 million respectively. Dermatological Skincare followed with a 17.0% constant currency increase, reaching $441 million in reported net sales. Management confirmed its full-year 2026 targets, projecting net sales growth between 17% and 20% and a Core EBITDA margin of approximately 26% at constant currency. Investors reacted positively to the beat-and-confirm report, pushing shares on the Swiss Stock Exchange up 5.84% to 159.55 francs. Additionally, the company will pay a dividend of 0.35 franc per share on April 28.

Sign up free to read the full analysis

Create a free account to unlock full AI-curated market articles, personalized alerts, and more.

Create Free Account Already have an account? Sign In
Share this article

Related Articles

Score 45 Bearish

Airbus Q1 Earnings Miss Estimates Amid Subsidiary Slump

Apr 29, 08:01

Score 68 Bullish

TotalEnergies Boosts Shareholder Returns Following Q1 Earnings Beat

Apr 29, 07:40

Score 42

UPM-Kymmene Reports Mixed Q1 Results; Energy Segment Hits Record Highs

Apr 29, 07:19

Score 42

Sandoz Reports Q1 Net Sales Growth Driven by Biosimilars Surge

Apr 29, 07:15

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Get Started Free View Plans
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI Chat
Markets
Profile